Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19 List of authors.
News
Policy & Recommendations
Flash Report: Third meeting of the Public Health Expert Group (PHEG)
Chaired by DG SANTE, EU Member States agreed on prioritising for 2024-2026: health promotion & prevention of non-communicable diseases; healthy longevity/lifelong prevention; vaccine-preventable diseases & vaccination; and long COVID, amongst others.
News
Scientific Papers
Article
Assessing the health burden of vaccine-preventable infections in European adults: challenges and opportunities translated into action
Accurate information on the health burden of vaccine-preventable infections (VPIs) is needed to support evidence-informed vaccine policy recommendations and programmes in Europe.
Article
News
Scientific Papers
The Adult Immunization Board (AIB): A new platform to provide multidisciplinary guidelines for the implementation and optimization of adult immunization in Europe
People can be at risk of getting and spreading serious vaccine-preventable infectious diseases throughout their lives and can therefore benefit from a lifelong approach to vaccination.
PROGRAMMING survey on educational needs in the care of older people
The COST Action Promoting geriatric medicine in countries where it is still emerging (PROGRAMMING) has launched a survey aiming to map the educational interests and needs of current and future healthcare professionals in the field of care for older people
Scientific Papers
News
Article
Effectiveness of community-based oral antiviral treatments against severe COVID-19 outcomes in people 70 years and over in Victoria, Australia, 2022: an observational study
Oral Antiviral (OAV) COVID-19 treatments are widely used, but evidence for their effectiveness against the Omicron variant in higher risk, vaccinated individuals is limited.
Scientific Papers
Article
News
Factors associated with delayed diagnosis of symptomatic adult COVID-19 cases presenting to primary care: a population-wide study during transition from Delta to Omicron BA.1 in Singapore
During pandemics, avoiding time delay in diagnosing infection is crucial.
Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan
CD8+ T cells provide robust antiviral immunity, but how epitope-specific T cells evolve across the human lifespan is unclear.
SARS-CoV-2-related mortality decrease in nursing home residents given multiple COVID-19 boosters
Two doses of COVID-19 mRNA vaccines in the primary series and a booster dose induce a strong antibody response, however, this response can be weak in people older than 80 years.
Viruses - a major cause of amyloid deposition in the brain
Clinically, Alzheimer's disease (AD) is a syndrome with a spectrum of various cognitive disorders.
The Path Towards Effective Respiratory Syncytial Virus Immunization Policies: Recommended Actions
RSV causes a substantial burden worldwide. After over six decades of research, there is finally a licensed immunization option that can protect the broad infant population, and other will follow soon.
|
ESWI Airborne: Burden of Disease
Burden of disease - A focus on acute respiratory viruses in older adults
Why should older adults be particularly careful of acute respiratory viruses? What are risk factors for adverse outcomes? Why is RSV typically under-diagnosed in adults compared with flu and what are some of the long-term impacts?
